Vext ScienceVEXT
VEXT logo
Fair Value
CA$0.95
Share price26 Jun
CA$0.2375.8% undervalued intrinsic discount
Loading
1Y35.29%
7D2.22%

Adult Use Expansion And Cultivation Gains Will Drive Stronger Long Term Cannabis Fundamentals

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
07 Dec 25
Updated
26 Jun 26
Views
8
Not Invested

Fair Value vs Share Price

CA$0.95
vs CA$0.2375.8% undervalued intrinsic discount
PastFuture-17m80m20172019202120232025202620272029Revenue US$80.2mEarnings US$2.9m
15.6%
Revenue growth
3.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Vext Science

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

Reasonable growth potential and fair value.

Market capCA$57.0m
PB0.7x
Estimated Growth14.2%
Dividend YieldN/A
Full analysis

CEO & management

Eric Offenberger
CEO
2.9yrs
CEO Tenure

Through its subsidiaries, engages in integrated cannabis operations in the United States.